SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000849146-18-000057
Filing Date
2018-05-09
Accepted
2018-05-09 16:08:11
Documents
45
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lfvn_033118x10q.htm 10-Q 760497
2 EXHIBIT 10.1 ex101-loanmodification.htm EX-10.1 44809
3 EXHIBIT 31.1 lfvn_033118xex311.htm EX-31.1 11537
4 EXHIBIT 31.2 lfvn_033118xex312.htm EX-31.2 11526
5 EXHIBIT 32.1 lfvn_033118xex321.htm EX-32.1 5665
6 EXHIBIT 32.2 lfvn_033118xex322.htm EX-32.2 5654
  Complete submission text file 0000849146-18-000057.txt   3308390

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT lfvn-20180331.xml EX-101.INS 447587
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfvn-20180331.xsd EX-101.SCH 27446
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lfvn-20180331_cal.xml EX-101.CAL 54419
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lfvn-20180331_def.xml EX-101.DEF 103969
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfvn-20180331_lab.xml EX-101.LAB 416655
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfvn-20180331_pre.xml EX-101.PRE 217322
Mailing Address 9785 S. MONROE STREET SUITE 300 SANDY UT 84070
Business Address 9785 S. MONROE STREET SUITE 300 SANDY UT 84070 801-432-9000
Lifevantage Corp (Filer) CIK: 0000849146 (see all company filings)

IRS No.: 841097796 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35647 | Film No.: 18818306
SIC: 2834 Pharmaceutical Preparations